Status:
NOT_YET_RECRUITING
A Hybrid Program to Prevent Substance Use Risk Among Upper Elementary School Students Using a Positive Youth Development Approach
Lead Sponsor:
Christopher Williams
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Vaping
E Cig Use
Eligibility:
All Genders
7-11 years
Phase:
NA
Brief Summary
The goal of this randomized controlled trial is to evaluate a psychosocial school-based hybrid intervention which includes traditional classroom sessions and online e-learning modules to reduce risk o...
Detailed Description
This SBIR Fast-Track proposal is designed to address the urgent problems of vaping and prescription drug misuse (PDM) among youth in the U.S. There is a dearth of primary prevention programs for vapin...
Eligibility Criteria
Inclusion
- Students will be eligible for participation if they attend a school enrolled in the trial and they are between ages 7-11.
Exclusion
- All students will be eligible to participate in intervention implmentation, but survey responses will be excluded from the formal analysis with documentation of significant cognitive impairment as determined by school officials.
Key Trial Info
Start Date :
January 1 2026
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2028
Estimated Enrollment :
3000 Patients enrolled
Trial Details
Trial ID
NCT07162155
Start Date
January 1 2026
End Date
August 1 2028
Last Update
September 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Health Promotion Associates
White Plains, New York, United States, 10604